Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
178 hedge funds and large institutions have $539M invested in Meridian Bioscience Inc in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 54 reducing their positions, and 23 closing their positions.
691% more call options, than puts
Call options by funds: $1.12M | Put options by funds: $141K
30% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 23
3% more funds holding
Funds holding: 172 → 178 (+6)
7% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 54
0% less capital invested
Capital invested by funds: $542M → $539M (-$2.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$11.6M |
| 2 |
JP Morgan Chase
New York
|
+$9.1M |
| 3 |
Millennium Management
New York
|
+$5.89M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.94M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$12.1M |
| 2 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$10.1M |
| 3 |
FAM
Fred Alger Management
New York
|
-$8.86M |
| 4 |
SCM
SG Capital Management
Chicago,
Illinois
|
-$5.24M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.07M |
VIVO Hedge Fund Activity: Q4 2017 in Review
178 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2017, worth a combined $539M — down 0.46% from $542M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new VIVO positions and 23 closed out — a net gain of 7 holders — while 58 added to existing stakes and 54 trimmed.
The largest buyer was Systematic Financial Management, adding an estimated $11.6M. The largest seller was Brown Capital Management, cutting an estimated $12.1M.
- 178 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2017, up from 172 in Q3 2017.
- Funds reported $539M of Meridian Bioscience Inc stock for Q4 2017, down 0.46% quarter-over-quarter.
- 30 funds opened new Meridian Bioscience Inc positions in Q4 2017 and 23 closed out, a net change of +7 holders.
- The largest Meridian Bioscience Inc buyer in Q4 2017 was Systematic Financial Management, an estimated $11.6M added.
- The largest Meridian Bioscience Inc seller in Q4 2017 was Brown Capital Management, an estimated $12.1M sold.
Based on aggregated 13F filings for Q4 2017.